SCHEMBL29913702

SCHEMBL29913702

O=C1CC[C@H](NC(=O)c2ncccn2)C(=O)N1

nearest known ligand 0.71

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 20/20 0.71
DDB1 Q16531 5/20 0.63
BRD4 O60885 2/20 0.59
IKZF3 Q9UKT9 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20128669 1.00 CRBN (0.71) CRBNDDB1BRD4IKZF3
SCHEMBL30918268 1.00 CRBN (0.71) CRBNDDB1BRD4IKZF3
SCHEMBL30066328 0.83 CRBN (1.00) CRBNDDB1BRD4IKZF3
SCHEMBL20128668 0.83 CRBN (1.00) CRBNDDB1BRD4IKZF3
SCHEMBL30760758 0.83 CRBN (1.00) CRBNDDB1BRD4IKZF3
SCHEMBL29568563 0.83 CRBN (1.00) CRBNDDB1BRD4IKZF3
SCHEMBL20812427 0.81 CRBN (0.66) CRBNDDB1BRD4IKZF3
SCHEMBL25626935 0.81 CRBN (0.53) CRBNDDB1BRD4IKZF3
SCHEMBL25627049 0.81 CRBN (0.53) CRBNDDB1BRD4IKZF3
SCHEMBL23874568 0.80 CRBN (0.65) CRBNDDB1BRD4IKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118638043-A Compounds and methods for targeted degradation of androgen receptor 阿尔维纳斯运营股份有限公司 2024-09-13 CN disclosed
CN-118059104-A Compounds and methods for targeted degradation of androgen receptor 阿尔维纳斯运营股份有限公司 2024-05-24 CN disclosed
CN-115175901-B Compounds and methods for targeted degradation of androgen receptor 阿尔维纳斯运营股份有限公司 2024-03-22 CN disclosed
EP-4077309-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas Operations, Inc. (US) 2022-10-26 EP disclosed
CN-115175901-A Compounds and methods for targeted degradation of androgen receptor 阿尔维纳斯运营股份有限公司 2022-10-11 CN disclosed